ClinicalTrials.govpublic full text
Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care
hereditary tyrosinemia, type i, ht-1, hypertyrosinemia type 1, orfadin, long term safety, hereditary tyrosinemia type 1, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811088
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.